JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SPRO - Spero Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SPRO Stock
Financials
Financials SPRO Stock
Loading...
Loading...
Income Statement
Income Statement SPRO Stock
Balance Sheet
Balance Sheet SPRO Stock
Cash Flow Statement
Cash Flow Statement SPRO Stock
Loading...
Loading...
SPRO Financials - Spero Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Spero Therapeutics, Inc. (SPRO)
Financials
Financials of SPRO
Loading...
Loading...
Loading...
Loading...
Revenue
$66.802M
Operating Income
$6.314M
Net Income
$8.572M
Share Count (Basic)
56.020363M
Operating Cash Flow
$-12.624M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$40.265M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2021
FY2022
FY2023
Revenue $USD
0
10M
20M
30M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-80M
-60M
-40M
-20M
0
20M
Annual
Quarterly
Margins
Gross
Operating
Net
-500%
-400%
-300%
-200%
-100%
0%
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-10M
0
10M
20M
30M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-3000%
-2000%
-1000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26